Lending marketplace Upstart has received conditional approval from the Office of the Comptroller of the Currency (OCC) to establish a bank called Upstart Bank, N.A. The conditional approval follows Upstart's application submitted in March and marks a key milestone in the company's efforts to operate a nationally chartered bank, the company said in a Thursday (July 23) press release.
Upstart Holdings, Inc. (UPST) closed the most recent trading day at $26.93, moving 2.39% from the previous trading session.
Upstart: Undervalued Relative To Its Growth Story
Upstart Holdings, Inc. (UPST) closed the most recent trading day at $28.64, moving 2.15% from the previous trading session.
Recently, Zacks.com users have been paying close attention to Upstart (UPST). This makes it worthwhile to examine what the stock has in store.
In the closing of the recent trading day, Upstart Holdings, Inc. (UPST) stood at $30.88, denoting a -2.25% move from the preceding trading day.
Upstart Holdings, Inc. (UPST) closed at $31.81 in the latest trading session, marking a -3.78% move from the prior day.
Upstart (UPST) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Upstart benefits from moderating macro risks, strong loan origination growth, and expanding funding partnerships, with the automated originations at 91% improving margins. The management reiterates strong FY2026/FY2028 guidance, with it underscoring a multi-year, profitable growth cadence despite the mixed FQ1'26 performance metrics. Readers are well advised to temper their expectations entering UPST's FQ2'26 earnings call, attributed to the likely lumpy loan originations during the prior Iran conflict.
Upstart's outlook rests on whether committed funding, AI automation and newer products can turn its loan rebound into steadier growth.
Upstart is widening its AI lending platform into Auto, Home and HELOCs, but lower take rates and margin pressure keep execution in focus.
Upstart's revenue rebound and funding wins support patience, but margin pressure and timing risks keep its buy case from looking fully confirmed.